In recent decades, liver fibrosis has been rigorously investigated in in vitro models (LX-2 cells and human primary HSCs), often through TGFβ1 stimulation, which elicits a response in the HSC phenotype and a shift in gene expression towards a fibrotic phenotype [13]. The gene discussed is TGFB1; the disease is Hepatic fibrosis.